MesobanK UK: an international mesothelioma bioresource.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Rintoul, Robert C
Rassl, Doris M
Gittins, Jacki
Marciniak, Stefan J
MesobanK collaborators
Abstract
Malignant pleural mesothelioma causes the greatest societal burden of all the asbestos-related diseases. Progress in better understanding tumour biology will be facilitated by the availability of quality-assured annotated tissue. MesobanK has been created to establish a bioresource of pleural mesothelioma tissue linked to detailed anonymised clinical data. When complete, the bioresource will comprise a 750-patient tissue microarray and prospectively collected tissue, blood and pleural fluid from 300 patients with mesothelioma. Twenty-six new cell lines have also been developed. MesobanK meets all appropriate ethical and regulatory procedures and has recently opened to requests for tissue and data.
Description
Keywords
Asbestos Induced Lung Disease, Histology/Cytology, Mesothelioma, Pleural Disease, Biological Specimen Banks, Biomedical Research, Foundations, Humans, International Cooperation, Lung Neoplasms, Mesothelioma, Mesothelioma, Malignant, Pleural Neoplasms, United Kingdom
Journal Title
Thorax
Conference Name
Journal ISSN
0040-6376
1468-3296
1468-3296
Volume Title
71
Publisher
BMJ
Publisher DOI
Sponsorship
Medical Research Council (G1002610)
Medical Research Council (G0601840)
Wellcome Trust (100140/Z/12/Z)
Medical Research Council (G0601840)
Wellcome Trust (100140/Z/12/Z)
RCR and DMR are part funded by the Cambridge Biomedical Research Centre and the Cambridge Cancer Centre. RCR is also funded by the NIHR Clinical Research Network: Eastern.